Osteoarthritis Therapeutics Market By Drug Type (Nonsteroidal Anti-inflammatory Drugs {NSAIDs}, Analgesics, Disease-Modifying Osteoarthritis Drugs {DMOADs}, corticosteroids, Hyaluronic Acid Injections, Biologics, and Others), By Application (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, and Others), Route of Administration (Oral, Topical, Injectable, and Others), By End-User (Hospitals, Ambulatory Surgical Centers {ASCs}, Homecare Settings, and Clinics), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

---

Report Coverage:

By Drug Type

• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Analgesics
• Disease-Modifying Osteoarthritis Drugs (DMOADs)
• Corticosteroids
• Hyaluronic Acid Injections
• Biologics
• Other

By Application

• Ankle Osteoarthritis
• Hip Osteoarthritis
• Knee Osteoarthritis
• Shoulder Osteoarthritis
• Others

By Route of Administration

• Oral
• Topical
• Injectable
• Other

By End-User

• Hospitals
• Ambulatory Surgical Centres (ASCs)
• Homecare Settings
• Clinics

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Pfizer Inc.
• Johnson & Johnson
• Novartis AG
• Sanofi S.A.
• GlaxoSmithKline
• Eli Lilly and Company
• AbbVie Inc.
• Merck & Co., Inc.
• Bayer AG
• Ferring Pharmaceuticals
• Regeneron Pharmaceuticals, Inc.
• Flexion Therapeutics, Inc.
• Anika Therapeutics, Inc.
• Zimmer Biomet Holdings, Inc.
• Bioventus LLC
• Kolon Life Science, Inc.
• TissueGene, Inc.
• Samumed, LLC
• Genzyme Corporation